Health ❯Healthcare ❯Clinical Trials

Phase 3 Trials

Efficacy Studies SURMOUNT-OSA Weight Loss Medications Drug Efficacy Eli Lilly Trials Eli Lilly AEGEAN Trial BRUIN CLL-321 Study Zepbound Trial Results FRESCO-2 Trial

FDA Clears At-Home Leqembi Injection for Weekly Maintenance in Early Alzheimer’s

The new 360 mg weekly autoinjector lets eligible patients continue therapy after 18 months of infusions with comparable benefits and safety.

Aficamten Tops Metoprolol in Obstructive HCM as Mavacamten Misses in Nonobstructive Trial

Remote Coaching Program Drives One-Year Weight Loss in Large Breast Cancer Trial

European Commission Approves Ogsiveo as First Therapy for Desmoid Tumors

FDA Approves First New Fibromyalgia Treatment in 15 Years

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

Padcev and Keytruda Combo Extends Survival in Bladder Cancer Trial

FDA Approves First Systemic Therapy for H3 K27M-Mutant Diffuse Midline Glioma

Novel Alzheimer’s Antibody Moves to Phase III After 90% Plaque Clearance

EU Backs First Twice-Yearly Injectable for HIV Prevention

Phase 3 Trial Validates Low-Dose Olanzapine for Chemo-Induced Nausea Without Heavy Sedation

FDA Approves IL-23 Inhibitor Tremfya for Moderate-to-Severe Crohn’s Disease

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Eli Lilly’s Oral Pill Matches Injectable GLP-1 Drugs in Phase 3 Diabetes Trials

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk

Inherited Mitochondrial Variant Linked to Checkpoint Inhibitor Resistance in Metastatic Melanoma

Triplet Therapy Doubles Survival in BRAF V600E Metastatic Colorectal Cancer

Roche’s New Antibiotic Against Acinetobacter baumannii Advances to Phase III Trials

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data